血液净化在肝移植围手术期的应用  被引量:2

Perioperative blood purification in patients undergoing orthotopic liver transplantation

在线阅读下载全文

作  者:邢同海[1] 彭志海[1] 徐琴君[1] 张政[1] 曹迅 

机构地区:[1]上海交通大学附属第一人民医院普通外科上海市器官移植中心,200080

出  处:《中华普通外科杂志》2007年第4期262-265,共4页Chinese Journal of General Surgery

基  金:上海市科学技术发展基金(024119602)

摘  要:目的 探讨血液净化在肝移植围手术期患者中的应用价值。方法 回顾性分析42例肝移植围手术期患者进行血液净化包括血浆置换(plasma exchange,PE)和持续肾脏替代治疗(continuous renal replacement therapy,CRRT)的结果。结果 29例肝移植患者移植前后行PE治疗(其中5例联合血液灌流),25例患者顺利过渡到肝移植,移植后的25例患者1年存活率为68%。PE治疗前后CD3^+分别为70.5%±9.3%及53.9%±6.4%,CD8^+(29.7%±8.1%,18.9%±7.3%)和CD25^+(12.3%±6.4%,9.6%±5.9%)下降,CD20^+10.9%±6.9%,22.0%±8.6%)上升.IgG[(16.9±2.4)g/L,(12.2±1.5)g/L]和IgA[(6.4±1.5)g/L,(3.6±0.8)g/L)]下降,补体C3[(0.35±0.17)g/L,(0.60±0.19)g/L)]和CH50[(9.6±3.0)×10^4U/L,(15.7±1.3)×10^4U/L]增高。19例患者移植前后进行CRRT治疗,9例肾功能恢复,移植后存活7例。移植后需要CRRT支持的17例患者1年存活率为41.2%。7例患者既行PE又行CRRT治疗,移植后4例存活。治疗期间无严重并发症发生。结论 血浆置换可以改善患者凝血功能及一般情况;肝移植加人工肝支持系统是治疗肝衰竭的有效方法;以CRRT为基础的综合疗法能有效治疗肝移植术后急性肾衰竭的患者。Objective To investigate the role of perioperative blood purification in patients undergoing orthotopic liver transplantation. Methods The clinical data were analyzed retrospectively in 42 patients receiving blood purification including plasma exchange ( PE ) and continuous renal replacement therapy (CRRT) during perioperative period. Results Twenty-nine liver transplantation candidates received PE and 25 were tided-over to undergo liver transplantation with a one year survival rate of 68%. After PE, CD3^+ (70.5% ±9.3%,53.9% ±6.4%), CD8^+ (29.7% ±8.1%,18.9% ±7.3%) and CD25^+(12.3% ±6.4%,9.6%±5.9%) cells decreased , CD20^+ (10.9% ±6.9%,22.0% ±8.6%) cellsincreased,IgG [(16.9 ±2. 4) g/L,(12.2± 1.5) g/L] and IgA [(6.4± 1.5) g/L ,(3.6 ± 0.8) g/L] decreased, C3 [(0.35 ±0. 17)g/L,(0.60 ±0. 19) g/L] and CH50 [(9.6±3.0) ×10^4 U/L, ( 15.7± 1.3 ) × 10^4 U/L] increased. Nineteen patients underwent CRRT and renal function recovered in 9 cases among them 7 cases survived a liver transplantation. Posttransplant acute renal failure in 17 cases necessitating CRRT resulted in a 1-year survival rate of only 41.2%. Seven patients underwent both PE and CRRT, finally 4 patients recovered. In this group there was no significant complications derived from blood purification. Conclusions PE can improve the coagulation and general state; Liver transplantation plus artificial liver support system is one of the most effective therapies for chronic liver failure patients ; The systemic therapy based on CRRT benefit acute renal failure in patients of liver transplantation during perioperative period.

关 键 词:肝移植  人工 血浆置换 连续肾脏替代治疗 

分 类 号:R686[医药卫生—骨科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象